Rep. Susan Wild

Maddy summaryHR 2584, the SAVE Act, creates a new federal criminal offense for assaulting or intimidating hospital employees while they're performing their duties, punishable by up to 10 years in prison, with enhanced penalties for using weapons, causing injury, or during public emergencies. The bill authorizes $25 million annually in federal grants to hospitals for violence prevention programs, including staff training, security technologies like panic buttons and video surveillance, and coordination with law enforcement. It defines "hospital" broadly to include various medical facilities such as long-term care hospitals, rehabilitation facilities, and critical access hospitals. The legislation directly affects hospital workers and medical facilities by establishing federal criminal penalties for violence against employees and providing funding to improve workplace safety. The law aims to address the rising problem of workplace violence against healthcare workers, which the bill states has increased since 2011.

Maddy summaryThe Family Violence Prevention and Services Improvement Act of 2023 amends the Family Violence Prevention and Services Act to improve services for victims of domestic violence, dating violence, and family violence. The bill authorizes $270 million annually for fiscal years 2024-2028, with specific allocations including 12.5% for Tribal grantees, 2.5% for culturally specific services, and funds for national hotlines and resource centers. It establishes a national domestic violence hotline, a National Indian Domestic Violence Hotline, and resource centers for Alaska Native and Native Hawaiian populations, requiring all services to be trauma-informed, culturally relevant, and accessible to underserved populations including racial and ethnic minorities, people with disabilities, and Tribal communities. The bill also mandates a study on financial stability support for survivors of domestic violence.

Maddy summaryHR 2602, the Small Business Child Care Investment Act, reclassifies eligible nonprofit child care centers as "small business concerns" under federal loan programs. This allows organizations meeting specific criteria - like state licensing, 501(c)(3) tax status, and non-discrimination policies - to access SBA Section 7(a) loans and Title V financing. The bill requires loan guarantees for amounts over $500,000 but eliminates denial of loans solely due to religious activity (per First Amendment protections). It mandates annual SBA reports tracking loan numbers and amounts provided to these child care providers. The law directly affects nonprofit child care centers serving children from birth to school age.

Maddy summaryHR 2630, the Safe Step Act, requires group health plans and health insurance issuers to establish a clear, transparent process for patients or their doctors to request exceptions to medication step therapy protocols. These protocols typically force patients to try cheaper drugs first before covering more expensive alternatives. The bill mandates that plans must approve exceptions when prior treatments failed, delay would cause serious harm, a treatment is unsafe, or a patient is stable on a previously approved drug, with strict 72-hour (or 24-hour in emergencies) decision timelines. It also requires plans to publish the exception process online and limit documentation requests to only necessary medical information. This law directly affects health insurers, employers offering health plans, and patients using step therapy for prescription drugs.

Maddy summaryHR 2439, the Ally’s Act, requires most private health insurance plans to cover hearing-related services and devices for qualifying individuals. It mandates coverage for cochlear implants, bone conduction devices, maintenance, upgrades every five years, hearing assessments, surgery, and rehabilitation, without separate cost-sharing or medical necessity reviews. This directly affects people with hearing loss who need implantable devices, as defined by a physician or audiologist. The law applies to group health plans under the Public Health Service Act, ERISA, and Internal Revenue Code, taking effect for plan years beginning January 1, 2025.

Resident Physician Shortage Reduction Act of 2023 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for qualifying hospitals, including hospitals in rural areas and health professional shortage areas. Current law provides for an increase of up to 200 positions per fiscal year beginning in FY2023, with a total increase of 1,000 positions; each hospital may receive up to 25 additional positions. Current law also provides for an additional increase of up to 200 positions for FY2026, with at least 100 of these positions for psychiatry or related specialties; each hospital may receive up to 10 additional positions. The bill provides for an additional increase of 2,000 positions per fiscal year from FY2025-FY2031; during this period, each hospital may receive up to 75 additional positions in total under the bill and current law. Additionally, one-third of the positions that are made available under the bill must be allocated to hospitals that are already operating above applicable resident limits. The bill also requires the Government Accountability Office to report on strategies to increase the diversity of the health professional workforce, including with respect to representation from rural, low-income, and minority communities.

Maddy summaryHR 1839, the Combating Illicit Xylazine Act, makes the illicit use and distribution of xylazine a federal crime by adding it to the Controlled Substances Act. The bill broadly defines xylazine to cover numerous chemical variants and prohibits human use or non-licit distribution, while preserving legitimate veterinary and pharmaceutical uses. It requires tracking xylazine in drug supply chains and mandates two reports to Congress within 1 and 4 years on its prevalence, sources, and whether it should be rescheduled. The bill directly affects individuals distributing or using xylazine illicitly, including as an additive to drugs like fentanyl, and aims to address its public health risks. Congress declared illicit xylazine an "emerging drug threat" under existing law.

Maddy summaryHR 1826 (PSA Screening for HIM Act) requires health insurance plans and issuers to cover prostate cancer screenings without out-of-pocket costs for men aged 40 and over who are at high risk of prostate cancer. This directly affects African-American men and men with a family history of prostate cancer (defined as having a first-degree relative diagnosed with or who died from prostate cancer). The bill mandates coverage for evidence-based screenings under the same requirements as other preventive services, effective for plan years starting January 1, 2024. It aims to address disparities in prostate cancer outcomes by removing financial barriers to early detection for high-risk groups.

Maddy summaryThe Women's Health Protection Act of 2023 would protect access to abortion services by prohibiting states from imposing restrictions that are more burdensome than those for comparable medical procedures. The bill would ensure people can obtain abortion services before fetal viability without unnecessary limitations like mandatory waiting periods or biased counseling, and after viability when necessary to protect the patient's life or health. It would preempt state laws that conflict with these protections and allow for civil enforcement actions to challenge restrictive state laws. This bill directly affects people seeking abortion services (including transgender and nonbinary individuals who can become pregnant), health care providers, and states that have implemented abortion restrictions.

Maddy summaryHR 1465, "Violet’s Law," requires federal research facilities to establish standards for placing eligible animals (dogs, cats, primates, guinea pigs, hamsters, rabbits) no longer needed for research with animal rescue organizations, sanctuaries, shelters, or individuals. Federal departments and agencies operating such facilities must create these placement standards within one year of the law's enactment. The law mandates that animals must be vet-certified as healthy (free of infectious disease or physical issues) before placement and prohibits facilities from using animals for commercial trade, breeding, or public exhibitions. This policy directly affects federal research facilities and aims to provide permanent homes for research animals through defined, safe pathways.